CHOICE OF AN ADEQUATE THERAPY REGIMEN FOR ACUTE ENTERIC INFECTIONS IN CHILDREN: RESULTS OF A RANDOMIZED TRIAL, 2016
T.A. RUZHENTSOVA, A.V. GORELOV, A.A. PLOSKIREVA
The paper shows the necessity of choosing an enterosorbent for acute enteric infection (AEI) in children. It presents the basic properties of polymethylsiloxane polyhydrate as one of the drugs for enterosorption.
ROTAVIRUS INFECTION IN NEWBORNS CHILDREN: CLINICAL PERFORMANCE, TREATMENT AND PROPHYLAXY, 2004
TUNDA I. P.
Health Care Practice has proposed effective preventive measures based on the results of clinical and virological studies and determining RVI leading risk factors in infants.
In the practice of maternity and neonatology departments, specialized clinical virological and microbiological monitoring of RVI in newborns has been offered for early diagnosis and prevention of nosocomial RVI.
In complex care unit optimum schemes and methods of administration of recombinant interferon – Laferon in the dose of 50-100,000 IU / kg 2 times a day, in enemas, within 3-5 days has been offered; Enterosgel in the dose of 5 g / kg 3 times a day orally for 5 days. To correct microflora, multyprobiotic Symbiter was applied in RVI treatment in 0.5 dose twice a day, orally, for 10 days.
COLLECTION OF RESEARCH PAPERS. ENTEROSGEL RESEARCHES, 2015
Dzyublik I, Shunko Em, Barbova A. Clinical efficacy of Enterosgel in treatment of rotovirus infections in newborns
Gorodetsky, Tebechevsky F Clinical efficacy of Enterosgel in treatment of patients with hepatitis A
Tkachenko E., Avalueva E. The Clinical Efficacy and safety of Enterosgel in the treatment of diarrhoea-dominant irritable bowel syndrome.
Tkachenko E., Avalueva E. The Clinical Efficacy and safety of Enterosgel in the treatment of Helicobacter Pylori – associated chronic gastroduodentis
Astahov V., Gusev V. The Clinical Efficacy and safety of Enterosgel in complex prevention of fetoplacental dysfunction in pregnant women with earlier syphilis
Usenko D., Gorelov A. The Clinical Efficacy of Enterosgel, in treatment of intestinal infections in chidren with atopic dermatitis.
Radchenko V., Seliverstov P. The Clinical Efficacy and safety of Enterosgel in treatment of predialysis Cronic Renal Falure (CRF) patients.
Nakhashova V. The Clinical Efficacy of Enterosgel in treatment of patients with Chronic Pancreatitis
Karlyichuk A., Kulachek F. The Clinical Efficacy of Enterosgel in complex treatment and prophylaxis of post-operative intraperitoneal in complication of acute cholecystitis
Moroz L., Paliy M. Use of enterosorbent Enterosgel in complex therapy of acute viral hepatitis B with concomitant intestinal dysbiosis
Sokolov E., Majev I. Clinical efficacy of Enterosgel in patients with digestive system-relative pathology.
Paliy I., Tchernobroviy V. Clinical efficacy of Enterosgel in complex treatment of intestinal dysbiosis
Yurchenko A., Nikolaev V. Clinical efficacy of Enterosgel in treatment of intoxication and diarrhoea in patients with AIDS during antiretroviral therapy.
USE OF ENTEROSGEL IN THE TREATMENT OF ALCOHOL INTOXICATION AND ITS CONSEQUENCES, 1990
Kajdaulova A.B., Vasilenko I.V.
Recently, the most challenging problem of narcology is treatment of alcohol intoxication, removal of drunkenness and reduction of withdrawal syndrome.
The complexity of massive elimination of the consequences of alcohol intoxication and treatment of acute psychosomatic disorders arising from it is a result of highly polymorphic disorders associated with significant changes in homeostasis.
An important factor in worsening of these conditions is disruption of the detoxification function of liver and excretory function of kidneys in people consuming alcohol excessively.
Detoxification herapy is the leader in a group of curative measures aimed at correcting homeostasis disorders and reduction of toxic effects of alcohol.
There was studied the influence of medicinal preparations, created on the base of methylsiliconorganic matrix, on immediate and late follow-up result of treatment of more than 2000 patients with the digestive channel malignancy. High efficacy of application in complex of preoperative preparation of immobilized antibiotics and cytostatics, enterosorpent enterosgel for the purulent-inflammatory complications prophylaxis, lowering of bilirubin level in tumoral obturative jaundice, and in intraoperative usage for the tumor and metastases recurrences prophylaxis.
ENTEROSORPTION IN EMERGENCE LUNG TUBERCULOSIS, 2015
Jugostran V.Ya., Sharikov Yu.N., Esaulova Т.А.
In a controlled open single center trials the results of chemotherapy newly diagnosed patients with pulmonary tuberculosis in combination with enterosorption one of three drugs: Enterosgel (polymethylsiloxane polyhydrate), aerosil or carbon sorbent. The effect on the performance of enterosorption intoxication and liver function during chemotherapy. As a result, due to hepatoprotective and detoxification effect enterosorption, managed to avoid the interruption of chemotherapy.
ADSORPTION ACTIVITY OF ENTEROSGEL TOWARD ROTAVIRUS, 1997
Jilin V.N., Dzyublik I.V., Barbova A.I.
Every year the range of problems associated with use of sorption technologies in various fields of medicine is expanding. Growing use of sorption processes, in turn, leads to improvement of the properties of older types of sorbents and creation of new sorbents with improved properties and enhanced sorption selectivity toward certain substances. Comparative medico-biological studies of various polymeric materials has shown prospectivity of medical use of organopolysiloxane adsorbents, particularly of polymethylsiloxane (PMS) and its hydrogel, Enterosgel, which consists of a spatially cross-linked porous matrix with a rigid globular structure formed by siloxane chain containing methyl and partially uncondensed hydroxyl groups in silicon atoms. The presence of hydrocarbon radicals provides high affinity of Enterosgel to organic substances (organophilic properties), that is to the toxic metabolites of various nature. In contrast to the known carbon sorbents and highly dispersity silicas, Enterosgel is characterized by apparent selectivity.
USE OF ENTEROSGEL IN THE TREATMENT OF ROTAVIRUS INFECTION IN THE NEWBORNS, 1997
Dzjublik I.V., Kham E.E., Barbova A.I.
The results of clinical and laboratory research confirmed high efficiency of use of Enterosgel in the treatment of newborn infants with rotavirus infection. Regarding the data collected, it is possible to draw a conclusion about the possibility and the need to use Enterosgel for treatment of diarrhea caused by rotavirus in newborns and prevention of infectious complications.